EMC testing, electrical safety evaluation, and certification support for medical electrical equipment in the US and Canada
EMC testing, electrical safety evaluation, and certification support for medical electrical equipment in the US and Canada

Medical electrical equipment sold in the US, Canada, and Europe must meet electromagnetic compatibility (EMC) and electrical safety requirements before it can reach the market. The primary framework governing these requirements is IEC 60601, a standard first published in 1977 and now in its third and fourth editions, adopted across more than 100 countries.
QAI provides accredited medical electronic device EMC testing, immunity evaluation, electrical safety, risk and cybersecurity assessment from labs in British Columbia, California, and Ohio, with certification recognized by the FDA, Health Canada, and international bodies under the IECEE CB Scheme.
Medical device EMC testing evaluates whether a device generates electromagnetic interference that could affect other equipment, and whether it can operate correctly in the presence of external electromagnetic fields. For medical electrical equipment, this is a patient safety issue as much as a regulatory one. IEC 60601-1-2 Edition 4, adopted in the US, Canada, and Europe by December 31, 2018, sets the current EMC requirements including essential performance criteria.
Testing areas covered include:

Radiated emissions testing per IEC 60601-1-2

ESD and immunity testing for medical equipment

Wireless coexistence testing per AIM 735731

CB Scheme certification for international market access

IEC 60601-1-2 Edition 4 made EMC compliance more rigorous by linking it to essential performance, meaning a device that malfunctions during an EMC test event is now considered to have failed the test, not just degraded. This change placed responsibility on manufacturers to define and demonstrate essential performance upfront, before testing. For devices with wireless modules, the FDA’s guidance on radio frequency wireless technology adds another layer of documentation that must be addressed separately from IEC 60601. Failing to address these requirements before submission can result in costly redesigns, delayed approvals, and deferred market entry.
To support more efficient certification and market entry for medical devices, the FDA has strengthened and streamlined its review process. ASCA accreditation plays an important role in this process, and QAI certifies many medical devices for the North American market.

Requirements vary by device, target market, and intended use. Contact us to confirm the full scope for your product.
| Standard | Scope |
| IEC 60601-1-2 Ed. 4 | EMC requirements for medical electrical equipment (all markets) |
| IEC 60601-1 Ed. 3 | General safety and essential performance |
| ISO 14971 | Risk management for medical devices (recognized by FDA, Health Canada, TGA) |
| ISO 13485 | Quality management systems for medical device manufacturers |
| AIM 735731 | RFID susceptibility and wireless coexistence testing |
| ANSI C63.4 | Radiated and conducted emissions measurement (US market) |
| FCC Part 15 / Part 18 | US authorization for intentional and unintentional radiators |
| ISED RSS-210 / RSS-Gen | Canadian radio authorization requirements |
| EU MDR 2017/745 | European Union Medical Device Regulation (CE marking pathway) |
| IECEE CB Scheme | International mutual recognition for electrical safety and EMC |

Patient monitors and hospital monitoring systems

Surgical, cosmetic, and therapeutic laser devices

Home healthcare and remote monitoring devices

Ultrasound and medical imaging equipment
QAI’s EMC lab is accredited by A2LA to ISO/IEC 17025 and is registered with the FCC and Innovation, Science and Economic Development (ISED) Canada, as well as other international regulatory bodies. QAI is recognized by OSHA as a Nationally Recognized Testing Laboratory (NRTL), holds accreditations with the Standards Council of Canada (SCC) for specific certification activities, and is recognized by the IECEE as a CB Testing Laboratory (CBTL), supporting international IEC standard-based certification. For the full scope of accreditations applicable to your product and target market, visit QAI’s accreditations page.
QAI works with you to develop a test plan that covers EMC, essential performance, and electrical safety requirements for your target markets before testing begins, so there are no surprises on scope or cost. With accredited labs in California, Ohio, and British Columbia, and recognition under both the IECEE CB Scheme and OSHA NRTL programs, QAI can support your path to FDA, Health Canada, and international market authorization from a single point of contact. Contact us at:
📞 USA 888.540.4024 📞 CANADA 877.461.8378

Founded in 1995 by Steven Harris, QAI is an independent third-party testing, inspection and certification organization serving the building industry, government and individuals with cost effective solutions through our global, in-house capabilities and services.
QAI Laboratories is pleased to announce the signing of a Cooperation Agreement
QAI is proud to announce that our Code Evaluation Report (CER) services
USA 1(888)540.4024
Canada 1(877)461.8378
Europe info@qai.org
China china-info@qai.org
S Korea asia-info@qai.org
This is the content